2007
DOI: 10.1080/15321810701454573
|View full text |Cite
|
Sign up to set email alerts
|

Development, Evaluation, and Application of a Highly Sensitive Microtiter Plate ELISA for Human Bcl10 Protein

Abstract: Bcl10 (B-cell CLL/lymphoma 10) is a 233 amino acid CARD (caspase recruitment domain)-containing cellular protein, increasingly recognized as a mediator of NFkappaB activation in non-immune, as well as immune cells. Due to the importance of Bcl10 in diverse cell types, we developed a solid-phase, enzyme-linked immunosorbent (ELISA) assay to precisely measure Bcl10 in small volume cell lysates, using recombinant Bcl10 to standardize the assay. Standard curve measures Bcl10 from 0.25 ng/mL to 16 ng/mL, with very … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2008
2008
2015
2015

Publication Types

Select...
10

Relationship

10
0

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 20 publications
0
16
0
Order By: Relevance
“…The effectiveness of silencing in the HepG2 cells was demonstrated by Western blotting for TLR4 and by quantitative ELISAs for BCL10 (1,33) and for GRB10 (Blue Gene, Shanghai, China). Briefly, cells were grown to 60 -70% confluency in 6-well tissue culture clusters, and the medium of the growing cells was aspirated and replaced with 2.3 ml of fresh medium with serum.…”
Section: Methodsmentioning
confidence: 99%
“…The effectiveness of silencing in the HepG2 cells was demonstrated by Western blotting for TLR4 and by quantitative ELISAs for BCL10 (1,33) and for GRB10 (Blue Gene, Shanghai, China). Briefly, cells were grown to 60 -70% confluency in 6-well tissue culture clusters, and the medium of the growing cells was aspirated and replaced with 2.3 ml of fresh medium with serum.…”
Section: Methodsmentioning
confidence: 99%
“…After 24 h, the spent medium was exchanged with fresh growth medium. The effectiveness of silencing of BCL10 expression was determined by ELISA assay and Western blot (12,37).…”
Section: Methodsmentioning
confidence: 99%
“…Expression of BCL10 protein in control and CGN-treated NCM460 was determined by a solid-phase ELISA, developed for quantitative determination of BCL10 (8). Control or treated cells were lysed in RIPA buffer (50 mM Tris containing 0.15 M NaCl, 1% Nonidet P-40, 0.5% deoxycholic acid, and 0.1% SDS, pH 7.4), and the cell extracts were stored at Ϫ80°C until assayed by the ELISA.…”
Section: Methodsmentioning
confidence: 99%